Zhenjie H. Wu - Publications

Metachronous Contralateral Recurrence in Upper Tract Urothelial Carcinoma: A Multi-Institutional Competing-Risks Analysis From the ROBUUST 3.0 Registry.

Journal: Urology practice

Published: June 22, 2026

YAU-RCC spotlight: randomized controlled trials in renal surgery. Lessons from ROBOCOP II and OpeRa.

Journal: Minerva urology and nephrology

Published: June 19, 2026

Oncological outcomes of radical nephroureterectomy with or without lymphadenectomy and neoadjuvant therapy in cN+ UTUC: Insights from the ROBUUST registry.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: May 27, 2026

What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group.

Journal: World journal of urology

Published: April 24, 2026

Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry.

Journal: Minerva urology and nephrology

Published: April 23, 2026

Defining standards for retroperitoneal single-port (SP) robotic surgery: the Advancing Retroperitoneal International SP Excellence (ARISE) international Delphi consensus.

Journal: BJU international

Published: March 16, 2026

Enucleation versus enucleoresection in robotic partial nephrectomy: Real-world data from the multicenter YAU kidney cancer database.

Journal: Surgical oncology

Published: February 14, 2026

Integrated spatial and single‑cell transcriptomics maps disulfidptosis in renal cell carcinoma and reveals PDLIM1 as a prognostic biomarker and potential therapeutic target.

Journal: Translational oncology

Published: January 27, 2026

Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry.

Journal: Minerva urology and nephrology

Published: December 18, 2025

Biomaterial-Driven Integrated Therapy for Renal Cell Carcinoma: Renal Cancer Control and Kidney Injury Repair.

Journal: Research (Washington, D.C.)

Published: December 18, 2025

YAP promotes wound healing in diabetic mice by improving endothelial cell function via the regulation of SEMA3B.

Journal: Acta histochemica

Published: November 11, 2025

Perioperative and oncologic outcomes of extirpative surgery for upper tract urothelial cancer in octogenarians.

Journal: Urologic oncology

Published: October 30, 2025